This guideline has been revised based on the guidance provided by the World Health Organization (WHO), local evidence and experience with TB preventive treatment (TPT) implementation. The purpose is to guide implementation, the management of patients started on TPT and the monitoring and evaluation requirements. It is intended for clinicians, pharmacists and healthcare managers in the public and private sector.